Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche Re-Models Around Disease Areas, Pulls Together R&D And Commercial

Executive Summary

Roche is taking a dual approach in reorganizing its global R&D business by centering on key disease areas and consolidating its full operations, from R&D to marketing, along those lines

Related Content

Roche Makes Early Headway With Pharmaco-Diagnostics
Roche Makes Early Headway With Pharmaco-Diagnostics
Roche Mantra Is “Pipeline, Pipeline, Pipeline;” R&D Surge Continues In 2008
Roche Diagnostics CEO Is No Ugly Duckling: Schwan Picked To Head Parent Corp.
Roche Seeks Diagnostics To Pair With Cancer Drugs In $3 Billion Ventana Bid
Mergers May Buy Time, But Fundamental Change Is Necessary, GSK’s Garnier
Roche Continues To Eschew Big Acquisitions In Favor Of Targeted Deals
Pfizer’s Manufacturing Cost-Cutting May Leave Little Capacity For Growth
“One Pfizer” Restructuring Initiative Divides R&D And Sales Operations
Amgen Sizes Up Strategy: Small-Scale Acquisitions, Large-Scale R&D



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts